DIAGNOLOGIX, LLC — Department of Health and Human Services SBIR Phase II: 102

Description

DESCRIPTION provided by applicant The goal of the proposed work is to develop a simple robust and cost efficient circulating tumor cell CTC isolation system based on an innovative BUBLES BUoyancy enaBLEd Separation technology for point of care applications The feasibility of this technology has been recently established by using targeted microbubbles to isolate CTCs from blood samples in both research and clinical settings The Phase I goal has been achieved through the development and test of a microbubble separator harvester prototype device to capture rare tumor cells in more than ml of blood samples Under Phase II funding we propose to complete the engineering work by creating an inexpensive and user friendly automated CTC isolation system based on the core BUBLES technology to validate the system with a study using human blood samples and to broaden the use of isolated CTCs for more research and clinical applications in addition to the simple CTC enumeration In contrast to many other CTC isolation systems that generally require centralized laboratories to process samples our product which is much less complex to build and operate targets the primary care and small laboratory settings Compared to other competitors we will have less cost but faster production and broader market size for commercialization PUBLIC HEALTH RELEVANCE This Phase II grant aims to develop a simple to operate and inexpensive device for isolation of rare cell types from blood and other biological fluids This technology has the potential to improve cancer detection and management in community settings